Statewide evaluation of infection control measures for preventing coronavirus disease 2019 in hemodia-lysis facilities

Imagem de Miniatura
Arquivos
art_GUEDES_Statewide_evaluation_of_infection_control_measures_for_preventing_2021.PDF (156.54 KB)
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2021
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Autores
ASSIS, Denise Brandao de
MADALOSSO, Geraldine
Citação
CLINICS, v.76, article ID e3299, 4p, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE: This study aimed to evaluate the occurrence of coronavirus disease 2019 (COVID-19) in hemodialysis facilities and the occurrence of and risk factors for clustering of COVID-19 cases. METHODS: We conducted a cross-sectional online survey between March and July 2020, in all dialysis facilities in Sao Paulo state, using Google Forms. The online questionnaire contained questions addressing specific components of infection prevention and control practices and the number of cases during the COVID-19 pandemic. RESULTS: A total of 1,093 (5%) COVID-19 cases were reported among 20,984 patients; approximately 56% of the facilities had X1 cluster. Most facilities implemented various measures (such as allocation of dedicated COVID-19 areas/shifts, symptom screening, environmental disinfection, and maintenance of adequate ventilation) to prevent the transmission of severe acute respiratory syndrome coronavirus 2. Clustering of COVID-19 cases was suspected in only 7% of dialysis facilities. The only variable associated with this event was the performance of aerosol-generating procedures (odds ratio: 4.74; 95% confidence interval: 1.75-12.86). CONCLUSION: Attention should be paid to avoiding the performance of aerosol-generating procedures in dialysis facilities and monitoring the clustering of cases.
Palavras-chave
Hemodialysis, COVID-19, Cluster, Statewide Survey, Infection Control
URI
https://observatorio.fm.usp.br/handle/OPI/43860
Referências
  1. Centers for Disease Control and Prevention, INT ADD GUID INF PRE
  2. Couchoud C, 2020, KIDNEY INT, V98, P1519, DOI 10.1016/j.kint.2020.07.042
  3. Fang FC, 2021, CLIN INFECT DIS, V72, P2225, DOI 10.1093/cid/ciaa1654
  4. Hamilton F, 2021, LANCET RESP MED, V9, P687, DOI 10.1016/S2213-2600(21)00216-2
  5. Hsu CM, 2020, KIDNEY INT, V98, P1402, DOI 10.1016/j.kint.2020.10.005
  6. Ikizler TA, 2020, AM J KIDNEY DIS, V76, pS1
  7. Klompas M, 2021, JAMA SURG, V156, P113, DOI 10.1001/jamasurg.2020.6643
  8. Prefeitura da Cidade de Sao, INQ SOR SARS COV 2 E
  9. Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1
  10. World Health Organization, INF PREV CONTR HLTH

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/49
Carregar mais